The cost of Tymlos (abaloparatide) and Forteo (teriparatide) can vary significantly depending on insurance coverage, pharmacy, and whether a discount program is utilized. Both are anabolic agents used to treat osteoporosis.
How Much Does Tymlos Cost?
The average retail price for a 3-mL injection of Tymlos is approximately $2,100 to $2,500 [1]. Without insurance, the cost can be substantial. However, patient assistance programs may be available to reduce out-of-pocket expenses for eligible individuals [2].
What is the Price of Forteo?
Forteo also has a significant cost, typically ranging from $2,200 to $2,700 for a 2.4-mL prefilled pen [3]. Similar to Tymlos, commercial insurance and manufacturer coupons or patient assistance programs can help mitigate the financial burden for patients [3, 4].
How Do Their Costs Compare?
While both medications are similarly priced, there can be slight differences in their wholesale acquisition costs and the net price after rebates and discounts. The specific cost for an individual patient will depend heavily on their prescription drug plan's formulary, copayments, and deductibles. It is advisable to compare prices at different pharmacies and explore manufacturer discount programs for both Tymlos and Forteo to find the most cost-effective option [1, 3].
Are There Generic Versions Available?
As of now, neither Tymlos nor Forteo have generic versions available on the market. This contributes to their higher price points, as patent exclusivity protects them from direct competition [5].
When Do Their Patents Expire?
Understanding patent expiration is crucial for anticipating potential generic competition and future price changes. DrugPatentWatch.com tracks patent information for many medications, including Tymlos and Forteo. Specific patent expiration dates for these drugs would need to be consulted on such specialized databases [5].
What Are the Alternatives for Osteoporosis Treatment?
Beyond Tymlos and Forteo, other osteoporosis treatments include bisphosphonates (e.g., alendronate, risedronate), denosumab (e.g., Prolia), and various hormone-related therapies [6]. The choice of treatment often depends on a patient's specific condition, fracture risk, medical history, and cost considerations.
How Do Tymlos and Forteo Work?
Tymlos and Forteo are both parathyroid hormone (PTH) analogs. Tymlos contains abaloparatide, a peptide analog of PTH-related protein, while Forteo contains teriparatide, a recombinant form of human PTH [7]. Both medications work by stimulating bone formation, helping to increase bone mineral density and reduce the risk of fractures in patients with osteoporosis [7, 8].
What is the Clinical Data for Tymlos and Forteo?
Clinical trials have demonstrated the efficacy of both Tymlos and Forteo in reducing vertebral and non-vertebral fracture rates in postmenopausal women and men with osteoporosis [7, 8]. Differences in study designs and patient populations can make direct comparisons challenging, but both are considered potent anabolic agents [7].
What Are the Side Effects to Consider?
Common side effects for both Tymlos and Forteo can include pain in the arms or legs, nausea, headache, and fatigue [7, 8]. Forteo has a boxed warning for osteosarcoma observed in animal studies, though the risk in humans is not fully understood [7]. Tymlos also carries a boxed warning regarding a potential increased risk of osteosarcoma and other bone sarcomas based on animal studies [8]. Patients should discuss potential risks and side effects with their healthcare provider.
Sources:
[1] https://www.drugpatentwatch.com/drug/ Tymlos
[2] https://www.drugpatentwatch.com/drug/ Tymlos
[3] https://www.drugpatentwatch.com/drug/ Forteo
[4] https://www.drugpatentwatch.com/drug/ Forteo
[5] https://www.drugpatentwatch.com/
[6] https://www.drugpatentwatch.com/
[7] https://www.drugpatentwatch.com/drug/ Forteo
[8] https://www.drugpatentwatch.com/drug/ Tymlos